암 치료를 위한 TGF-β SIRNA 및 PDL1 SIRNA의 공동 전달

항-TGF-β siRNA 분자 및 항-PDL1 siRNA 분자를 포함하는 조성물이 제공된다. 또한 암을 치료하기 위해 이러한 조성물을 사용하는 방법이 제공된다. Compositions containing an anti-TGF-β siRNA molecule and an anti-PDL1 siRNA molecule are provided. Methods of using these compositions to treat cancer also are provided....

Full description

Saved in:
Bibliographic Details
Main Authors LU PATRICK Y, EVANS DAVID M
Format Patent
LanguageKorean
Published 09.08.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:항-TGF-β siRNA 분자 및 항-PDL1 siRNA 분자를 포함하는 조성물이 제공된다. 또한 암을 치료하기 위해 이러한 조성물을 사용하는 방법이 제공된다. Compositions containing an anti-TGF-β siRNA molecule and an anti-PDL1 siRNA molecule are provided. Methods of using these compositions to treat cancer also are provided.
Bibliography:Application Number: KR20227011766